The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials.
暂无分享,去创建一个
S D Walter | G H Guyatt | G. Guyatt | L. Griffith | S. Walter | H. Bucher | L E Griffith | H C Bucher | S. Walter
[1] J. Fleiss. Statistical methods for rates and proportions , 1974 .
[2] S. Spector,et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. , 1995, The New England journal of medicine.
[3] S. Kent,et al. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity , 1992, AIDS.
[4] H. Waskin,et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. , 1992, The New England journal of medicine.
[5] C. Gaudebout,et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. , 1993, The New England journal of medicine.
[6] G. Guyatt,et al. Combined effect size: comment on the metaanalysis of second-line drugs in rheumatoid arthritis. , 1991, Arthritis & Rheumatism.
[7] M. Moroni,et al. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial , 1996 .
[8] J. Miro,et al. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. , 1993, AIDS.
[9] M. Thorn,et al. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. , 1993, The American journal of medicine.
[10] R Goeree,et al. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[11] A. Antinori,et al. Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia , 1992, The Lancet.
[12] B. Marchou,et al. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses. , 1994, Journal of acquired immune deficiency syndromes.
[13] T C Chalmers,et al. A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.
[14] B. Hirschel,et al. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[16] Y. van der Graaf,et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. , 1992, The New England journal of medicine.
[17] D. Felson,et al. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. , 1990, Arthritis and rheumatism.
[18] J. Jiménez,et al. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients. , 1993, AIDS.
[19] B. Gazzard,et al. Patient tolerance of nebulized pentamidine or cotrimoxazole as secondary prophylaxis for Pneumocystis carinii pneumonia. , 1992, AIDS (London).
[20] D. Podzamczer,et al. Intermittent Trimethoprim-Sulfamethoxazole Compared with Dapsone-Pyrimethamine for the Simultaneous Primary Prophylaxis of Pneumocystis Pneumonia and Toxoplasmosis in Patients Infected with HIV , 1995, Annals of Internal Medicine.
[21] D. Cohn,et al. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. , 1992, Journal of acquired immune deficiency syndromes.
[22] G. Guyatt,et al. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[23] J. Nielsen,et al. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. , 1995, Scandinavian journal of infectious diseases.
[24] David T. Felson,et al. THE COMPARATIVE EFFICACY AND TOXICITY OF SECOND LINE DRUGS IN RHEUMATOID ARTHRITIS , 1990 .